Also, update research has highlighted that EZH2-mediated H3K27m3 blockade of cyclin-dependent kinase inhibitor 1C could suppress glycolysis, proliferation and migration of pancreatic cancer cells [43]. This evidence concerns the gene CDKN1C and familial pancreatic carcinoma.